📰 Knott David News
Knott David News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Knott David. Real-time updates on events, politics, business and more.
May 29, 2022
Shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) have been given an average recommendation of “Buy” by the nine brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among […]
May 20, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
May 17, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
May 7, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
April 11, 2022
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) – Analysts at Truist Financial decreased their FY2023 earnings per share (EPS) estimates for Iovance Biotherapeutics in a research note issued on Wednesday, April 6th. Truist Financial analyst A. Goonewardene now forecasts that the biotechnology company will earn ($2.17) per share for the year, down from their prior […]
April 11, 2022
Wall Street brokerages forecast that Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Rating) will announce $870.70 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Calumet Specialty Products Partners’ earnings, with the lowest sales estimate coming in at $856.50 million and the highest estimate coming in at […]
April 5, 2022
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Sunday. Several other equities analysts have also commented on CLMT. Zacks Investment Research lowered Calumet Specialty Products Partners from a “hold” rating to a “sell” rating in a research report […]
April 2, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.